Evidence for Non-Cancer-Specific T Cell Exhaustion in the Tcl1 Mouse Model for Chronic Lymphocytic Leukemia

The reinvigoration of anti-cancer immunity by immune checkpoint therapies has greatly improved cancer treatment. In chronic lymphocytic leukemia (CLL), patients as well as in the Tcl1 mouse model for CLL, PD1-expressing, exhausted T cells significantly expand alongside CLL development; nevertheless,...

Descripción completa

Detalles Bibliográficos
Autores principales: Parigger, Thomas, Gassner, Franz Josef, Scherhäufl, Christian, Bakar, Aryunni Abu, Höpner, Jan Philip, Hödlmoser, Alexandra, Steiner, Markus, Catakovic, Kemal, Geisberger, Roland, Greil, Richard, Zaborsky, Nadja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268419/
https://www.ncbi.nlm.nih.gov/pubmed/34206229
http://dx.doi.org/10.3390/ijms22136648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268419/
https://www.ncbi.nlm.nih.gov/pubmed/34206229
http://dx.doi.org/10.3390/ijms22136648

Ejemplares similares